Tissue-type plasminogen activator is a neuroprotectant in the central nervous system
- PMID: 26347605
- PMCID: PMC4538299
- DOI: 10.3389/fncel.2015.00304
Tissue-type plasminogen activator is a neuroprotectant in the central nervous system
Abstract
Tissue-type plasminogen activator (tPA) is a serine proteinase found not only in the intravascular space but also in a well-defined sub-set of neurons in the brain. tPA is rapidly released from neurons after either exposure to hypoxia or hypoglycemia in vitro, or the induction of cerebral ischemia in vivo. It has been proposed that tPA has a neurotoxic effect in the ischemic brain. However, recent evidence indicate that once released into the synaptic cleft tPA activates specific cell signaling pathways that promote the detection and adaptation to metabolic stress. More specifically, the non-proteolytic interaction of tPA with N-methyl-D-aspartate receptors (NMDARs) and a member of the low-density lipoprotein receptor (LDLR) family in dendritic spines activates the mammalian target of rapamycin (mTOR) pathway that adapts cellular processes to the availability of energy and metabolic resources. TPA-induced mTOR activation in neurons leads to hypoxia-inducible factor 1α (HIF-1α) accumulation, HIF-1α-induced expression and membrane recruitment of the neuronal transporter of glucose GLUT3, and GLUT3-mediated uptake of glucose. These and other data discussed in this Review suggest that the postulated neurotoxic effect of tPA needs to be reconsidered and instead indicate the emergence of a new paradigm: that tPA is an endogenous neuroprotectant in the central nervous system (CNS).
Keywords: cerebral ischemia; excitotoxicity; middle cerebral artery occlusion (MCAo); neuroprotection; neurovascular unit (NVU); plasminogen; tissue-type plasminogen activator (tPA).
Figures

Similar articles
-
Tissue-type plasminogen activator regulates the neuronal uptake of glucose in the ischemic brain.J Neurosci. 2012 Jul 18;32(29):9848-58. doi: 10.1523/JNEUROSCI.1241-12.2012. J Neurosci. 2012. PMID: 22815500 Free PMC article.
-
Tissue-type plasminogen activator mediates neuroglial coupling in the central nervous system.Neuroscience. 2014 Jan 17;257:41-8. doi: 10.1016/j.neuroscience.2013.10.060. Epub 2013 Nov 4. Neuroscience. 2014. PMID: 24200922 Free PMC article.
-
Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein mediate cerebral ischemia-induced nuclear factor-kappaB pathway activation.Am J Pathol. 2007 Oct;171(4):1281-90. doi: 10.2353/ajpath.2007.070472. Epub 2007 Aug 23. Am J Pathol. 2007. PMID: 17717150 Free PMC article.
-
Reprint of: Fibrinolytic and Non-fibrinolytic Roles of Tissue-type Plasminogen Activator in the Ischemic Brain.Neuroscience. 2024 Jul 9;550:21-29. doi: 10.1016/j.neuroscience.2024.05.040. Epub 2024 Jul 2. Neuroscience. 2024. PMID: 38964373 Review.
-
Fibrinolytic and Non-fibrinolytic Roles of Tissue-type Plasminogen Activator in the Ischemic Brain.Neuroscience. 2024 Mar 26;542:69-80. doi: 10.1016/j.neuroscience.2023.08.011. Epub 2023 Aug 11. Neuroscience. 2024. PMID: 37574107 Review.
Cited by
-
SHock-INduced Endotheliopathy (SHINE): A mechanistic justification for viscoelastography-guided resuscitation of traumatic and non-traumatic shock.Front Physiol. 2023 Feb 27;14:1094845. doi: 10.3389/fphys.2023.1094845. eCollection 2023. Front Physiol. 2023. PMID: 36923287 Free PMC article. Review.
-
Assessment of recombinant tissue plasminogen activator (rtPA) toxicity in cultured neural cells and subsequent treatment with poly-arginine peptide R18D.Neurochem Res. 2020 May;45(5):1215-1229. doi: 10.1007/s11064-020-03004-3. Epub 2020 Mar 5. Neurochem Res. 2020. PMID: 32140956
-
Lactoferrin-derived peptide PXL01 impacts nerve regeneration after sciatic nerve reconstruction in healthy and diabetic rats.Front Cell Dev Biol. 2025 Apr 7;13:1565285. doi: 10.3389/fcell.2025.1565285. eCollection 2025. Front Cell Dev Biol. 2025. PMID: 40260416 Free PMC article.
-
Tissue-type Plasminogen Activator (tPA) Modulates the Postsynaptic Response of Cerebral Cortical Neurons to the Presynaptic Release of Glutamate.Front Mol Neurosci. 2016 Nov 9;9:121. doi: 10.3389/fnmol.2016.00121. eCollection 2016. Front Mol Neurosci. 2016. PMID: 27881952 Free PMC article.
-
Targeting NMDA Receptors at the Neurovascular Unit: Past and Future Treatments for Central Nervous System Diseases.Int J Mol Sci. 2022 Sep 7;23(18):10336. doi: 10.3390/ijms231810336. Int J Mol Sci. 2022. PMID: 36142247 Free PMC article. Review.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous